Geneva, July 14 -- International Clinical Trials Registry received information related to the study (ACTRN12625000717459) titled 'Evaluating the User Experience with Omnipod 5: A whole lifespan trial' on July 7.
Study Type: Interventional
Study Design:
Purpose: Treatment
Allocation: Randomised controlled trial
Primary Sponsor: St Vincent's Hospital
Condition:
Type 1 Diabetes
Type 1 Diabetes
Metabolic and Endocrine - Diabetes
Intervention:
Omnipod 5 is a current generation Automated Insulin Delivery (AID) enabled tubeless insulin pump.
The aim is to conduct a randomised controlled study comparing the user experience with Omnipod 5 and 'usual care' in people living with Type 1 Diabetes (T1D).
Seventy-four adults with a diagnosis of ...